Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 5/20 | 0.45 |
| ▸ | TDO2 | P48775 | 2/20 | 0.41 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.38 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
| ▸ | CHUK | O15111 | 4/20 | 0.35 |
| ▸ | LCK | P06239 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.32 |
| ▸ | CLK1 | P49759 | 1/20 | 0.32 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17665351 | 0.82 | TDO2 (0.48) | TDO2IDO1CYP17A1 | |
| SCHEMBL17651977 | 0.80 | TDO2 (0.46) | TDO2IDO1 | |
| SCHEMBL17651987 | 0.80 | TDO2 (0.50) | TDO2IDO1 | |
| SCHEMBL17665353 | 0.79 | TDO2 (0.45) | TDO2IDO1MAPT | |
| SCHEMBL17665352 | 0.79 | TDO2 (0.47) | TDO2IDO1 | |
| SCHEMBL17652000 | 0.78 | TDO2 (0.46) | TDO2IDO1 | |
| SCHEMBL17651935 | 0.78 | TDO2 (0.46) | TDO2IDO1 | |
| SCHEMBL17651995 | 0.78 | TDO2 (0.46) | TDO2IDO1GPBAR1 | |
| SCHEMBL17651986 | 0.77 | TDO2 (0.43) | TDO2IDO1GPBAR1 | |
| SCHEMBL17665679 | 0.77 | TDO2 (0.41) | TDO2PRKCZROCK1ROCK2IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016051181-A1 | 4H-IMIDAZO[1,5-A]INDOLE DERIVATIVES AND THEIR USE AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) AND/OR TRYPTOPHAN 2,3-DIOXYGENASE (TD02) MODULATORS | REDX PHARMA PLC (GB) | 2016-04-07 | — | — | WO | disclosed |